Loading Complete
Ambroise Wonkam

Ambroise Wonkam, MD, PhD, DMSc

Pediatric Genetics

Medical Genetics

Accepting New Patients

Highlights

Languages

  • French
  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Ambroise Wonkam

Professional Titles

  • Henry J. Knott Director of the McKusick-Nathans Institute and Professor in Medical Genetics
  • Director of the Department of Genetic Medicine

Primary Academic Title

Professor of Genetic Medicine

Background

Dr. Ambroise Wonkam is a Professor of Genetic Medicine and Director of the McKusick-Nathans Institute and Department of Genetic Medicine at the Johns Hopkins University School of Medicine.

After receiving his medical degree from the Faculty of Medicine and Biomedical Sciences at the University of Yaoundé I in Cameroon, he completed a thesis in medical sciences at the University of Geneva in Switzerland and a Ph.D. in human genetics at the University of Cape Town, South Africa.  Dr. Wonkam received his training as a medical geneticist from the genetics department at the University of Geneva in Switzerland. He practices medical genetics in both European and African contexts.

His research interests are reflected in more than 250 peer-reviewed publications, which are in molecular, clinical, educational and ethical aspects of medical and human genetics. His research focuses on genetic modifiers of sickle cell disease, the genetics of hearing loss and ethical and educational issues in human genetics.

Over the past five years, Dr. Wonkam has let successfully led an NIH/NHGRI funded sickle cell disease project and is a co-applicant for a Wellcome Trust - DELTAS grant to develop capacity in human genetics on the African continent. He has recently received a $3.7 million award from NIH/NHLBI to pursue research activities of the Sickle Africa Data Coordinating Centre (SADaCC) for various studies in Tanzania, Nigeria, Zimbabwe, Zambia, Uganda, Mali and Ghana. In addition, under the current round of funding for the H3Africa Consortium, he was awarded three grants for the following projects: Hearing Impairment Genetic Studies in Africa (HI Genes Africa) from the NIH/NHGRI ($1.25 million), an AESA/Wellcome Trust project ($2.07 million) and a collaborative center grant from the NIH/NHGRI ($2.5 million) to support the study of Incidental Findings in Genetic Research in Africa (IFGENERA). He also received $2 million in NIH/NIMH support to fund the Public Understanding of Big Data in Genomics Medicine project in Africa (PUBGEM-Africa) for the next five years.

Dr. Wonkam was awarded the 2003 Denber-Pinard Prize for the best thesis from the Faculty of Medicine at the University of Geneva in Switzerland. He received the Clinical Genetics Society International Award in 2014 from the British Society of Genetic Medicine. In 2021, he received the Alan Pifer Award, which honors a University of Cape Town researcher whose outreach work has contributed to the advancement and welfare of South Africa’s disadvantaged people. He received the Human Genome Organisation African Prize in 2023 and was selected in 2022 as a faculty scholar by the Human Genome Organisation (HUGO). In 2022, he received the Gold Medal for Excellence in Research, awarded by the South African Medical Research Council. In 2021, he was elected as a member of the South African Academy of Sciences.

Dr. Wonkam is an associate editor of the American Journal of Human Genetics, the American Journal of Medical Genetics and the Journal of Community Genetics. He is an academic editor of PLoS One and a member of the editorial board of Human Genetics.

Dr. Wonkam is president of the African Society of Human Genetics, chair of the steering committee of H3Africa Consortium, a board member of the International Federation of Human Genetics Societies and a steering committee member of the Global Genetic Medicine Collaborative (G2MC). 

Recent News Articles and Media Coverage

  • Ambroise Wonkam: Making Human Genomics Truly Equitable, The Lancet (May 21, 2022)

  • World Renowned Geneticist and Sickle Cell Disease Expert Ambroise Wonkam Takes Helm of Genetic Medicine Department at Johns Hopkins, The Ritz Herald (Dec. 28, 2021)

  • Game Changers: Tinto, Muyembe, Wonkam…Pioneers of African health, The Africa Report (Dec. 16, 2021)

  • Why Africa urgently needs its own genetic library, My Joy Online (Nov. 2, 2021)

  • Collect More Data from Africa to Improve Gene Therapy, Nature (Aug. 25, 2021)

  • Alan Pifer Award: A Hat-Tip to Geneticist Professor Ambroise Wonkam, University of Cape Town (Aug. 3, 2021)

  • Sequence Three Million Genomes Across Africa, Nature, (Feb. 10, 2021)

Contact for Research Inquiries

773 N. Broadway, MRB 443
Baltimore, MD 21205

Research Interests

Ethics in Human Genetics, Genetics of Congenital Hearing Impairment, Sickle Cell Disease

Research Summary

Dr. Wonkam's research interests are reflected in more than 250 peer-reviewed publications, which are in molecular, clinical, educational and ethical aspects of medical and human genetics. His research focuses on genetic modifiers of sickle cell disease, the genetics of hearing loss and ethical and educational issues in human genetics.

Over the past five years, Dr. Wonkam has let successfully led an NIH/NHGRI funded sickle cell disease project and is a co-applicant for a Wellcome Trust - DELTAS grant to develop capacity in human genetics on the African continent. He has recently received a $3.7 million award from NIH/NHLBI to pursue research activities of the Sickle Africa Data Coordinating Centre (SADaCC) for various studies in Tanzania, Nigeria, Zimbabwe, Zambia, Uganda, Mali and Ghana. In addition, under the current round of funding for the H3Africa Consortium, he was awarded three grants for the following projects: Hearing Impairment Genetic Studies in Africa (HI Genes Africa) from the NIH/NHGRI ($1.25 million), an AESA/Wellcome Trust project ($2.07 million) and a collaborative center grant from the NIH/NHGRI ($2.5 million) to support the study of Incidental Findings in Genetic Research in Africa (IFGENERA). He also received $2 million in NIH/NIMH support to fund the Public Understanding of Big Data in Genomics Medicine project in Africa (PUBGEM-Africa) for the next five years.

Honors

  • Alan Pifer Award, University of Cape Town, 12/1/21
  • Gold Scientific Achievement Award, The South African Medical Research Council, 12/1/21
  • Clinical Genetics Society International Award, British Society of Genetic Medicine, 12/1/14
  • Denber-Pinard Prize for the best thesis, University of Geneva, Switzerland, 12/1/03

Memberships

  • American Society of Human Genetics,

    Member, Associate Editor of the American Journal of Human Genetics

  • European Society of Human Genetics,

    Member

  • African Society of Human Genetics,

    President

Additional Training

Medical genetics Specialist Certificate, University of Geneva, Switzerland (2005)

Locations

  1. Rubenstein Child Health Building
    • 200 North Wolfe Street, Rubenstein BLDG Lower Level, Baltimore, MD 21287

    Expertise

    Education

    Geneva University Hospital

    Residency, Medical Genetics, 2005

    University of Geneva School of Medicine

    Graduate School, Cell Biology, PhD, 2003

    University of Yaounde I, Faculty of Medicine and Biomedical Sciences

    Medical Education, MD, 1995

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)